Trial NCT03739138

View at ClinicalTrials.gov 
Org. Study IDs: 4621-002
Secondary IDs: 2018-000845-37 MK-4621-002

Last trial update was posted on 2022-02-28

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasms

Other Conditions

Advanced Solid Tumors

Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID